Intervention

dapagliflozin

ClinicalTrials.gov intervention label

Clinical trials12

Recruiting0

Common conditions9

Lead sponsors shown6

Clinical trials

12 shown

Efficacy of Dapagliflozin in Early Diabetic Nephropathy in Type 1 DiabetesNCT06532682 · 2024-07-01

Effects of SGLT-2 Inhibition on Myocardial Fibrosis and Inflammation as Assessed by Cardiac MRI in Patients With DM2NCT03782259 · 2019-02-26

A Clinical Study to Investigate the Effects of Dapagliflozin on Heart Work, Heart Nutrient Uptake, and Heart Muscle Efficiency in Type 2 Diabetes PatientsNCT03387683 · 2018-02-28

An Investigation Into The Anti-hypertensive And Potential Anti-inflammatory Actions Of DapagliflozinNCT02433678 · 2015-11-01

Mechanistic Study of the Systolic Blood Pressure Lowering Effect of Dapagliflozin in Type 2 DiabetesNCT02372955 · 2015-02-01

Phase 1 Study to Explore the Safety and Pharmacokinetics of DAPAglifozin in Adolescents and Adults With Type 1 DiabetesNCT02325206 · 2014-12-01

Evaluation of Safety and Efficacy of Dapagliflozin in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control on Background Combination of Metformin and SulfonylureaNCT01392677 · 2011-10-01

Evaluation of Dapagliflozin Taken Twice-dailyNCT01217892 · 2010-11-01

Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of Ultra Low Doses of Dapagliflozin in Healthy SubjectsNCT01135446 · 2010-05-01

Efficacy and Safety of Dapagliflozin in Combination With Glimepiride (a Sulphonylurea) in Type 2 Diabetes PatientsNCT00680745 · 2008-04-01

Efficacy and Safety of Dapagliflozin in Combination With Metformin in Type 2 Diabetes PatientsNCT00660907 · 2008-03-01

A Trial of BMS-512148 in Patients With Type 2 Diabetes MellitusNCT00263276 · 2005-12-01

Common conditions

Type 2 Diabetes6 Diabetes Mellitus Type 22 Type 1 Diabetes2 Type 2 Diabetes Mellitus2 Diabetic Kidney Disease1 High HbA1c Level1 Inadequate Glycaemic Control1 Myocardial Fibrosis1 Myocardial Inflammation1

Leading sponsors

AstraZeneca7 Gulf Regional Research & Educational Services, LLC1 Kinderkrankenhaus auf der Bult1 The First Affiliated Hospital with Nanjing Medical University1 University at Buffalo1 University of Washington1

Trial status mix

COMPLETED10

UNKNOWN2

Phase mix

PHASE45

PHASE34

PHASE12

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.